ECMO
ECMO is a medical procedure with 15 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
4
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
ECMO Treatment of Children in China in the Past 10 Years
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation
Early Versus Late Initiation of ECMO (Extracorporal Membrane Oxygenation) Trial (ELIEO-Trial)
China Extracorporeal Life Support Registry
Clinical Trials (15)
ECMO Treatment of Children in China in the Past 10 Years
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation
Early Versus Late Initiation of ECMO (Extracorporal Membrane Oxygenation) Trial (ELIEO-Trial)
China Extracorporeal Life Support Registry
Establishment of a Early Risk Model of ECMO in Children With ARDS
Comparison of Four Intensive Care Scores in Prediction of VA-ECMO Survival.
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Outcome of Patients Treated With ECLS
Extracorporeal Membrane Oxygenation (ECMO)
Pharmacokinetics in Extracorporeal Membrane Oxygenation
Growth of High-Quality Oxides on The Inner Surface of ECMO Circuit by ALD to Reduce Thrombus Formation
Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS)
Refractory Out-Of-Hospital Cardiac Arrest Treated With Mechanical CPR, Hypothermia, ECMO and Early Reperfusion
Refractory IHCA and OHCA Treated With ECMO
All 15 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 15